GlassScriptPhysician profile
Samir S Jain
NPI 1851312656
$32,234.96
in general payments reported to CMS, 2019-2025
32 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $628 · 2021: $391 · 2022: $489 · 2023: $559 · 2024: $9,491 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $7,625 · Food and Beverage: $3,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,700.00 |
| Travel and Lodging | $7,624.59 |
| Food and Beverage | $3,114.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $28,012.52 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Astrazeneca Pharmaceuticals LP | $586.09 | 2019-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $495.06 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.54 | 2022-2025 | Jardiance |
| Spinal Simplicity, LLC | $291.77 | 2020 | |
| Pfizer INC. | $288.33 | 2019-2025 | |
| Novo Nordisk INC | $280.33 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $256.54 | 2021-2025 | Aveir, Freestyle Libre 3, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $239.82 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $213.73 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $198.76 | 2019-2025 | Bodyguardian |
| Janssen Pharmaceuticals, INC | $179.11 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.16 | 2019-2025 | Lifevest |
| Abiomed | $144.09 | 2023 | Impella |
| Cvrx, INC. | $80.43 | 2024-2025 | Barostim Neo System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $79.26 | 2020 | |
| Baxter Healthcare | $70.03 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $68.65 | 2024-2025 | |
| Philips North America LLC | $31.24 | 2022-2024 | (5044) Mcot |
| Terumo Medical Corporation | $27.16 | 2019 | |
| Vital Connect, INC | $26.13 | 2025 | Vitalpatch Rtm |
| Silk Road Medical, INC. | $26.05 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Heartflow, INC. | $24.58 | 2025 | |
| Impulse Dynamics (USA) INC. | $18.51 | 2025 | Optimizer |
| Alnylam Pharmaceuticals INC. | $18.11 | 2025 | Onpattro |
| Esperion Therapeutics, INC. | $16.79 | 2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $15.94 | 2024 | Assure Wcd |
| Aurinia Pharma U.S., INC. | $15.34 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.75 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2019 | |
| Gilead Sciences, INC. | $14.08 | 2019 | |
| Medicure Pharma INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.